Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Expands Focus with Development of New NanoAb Therapeutics

Last September, a joint steering committee comprising professionals from BiondVax Pharmaceuticals (NASDAQ: BVXV), the Max Planck Institute for Multidisciplinary Sciences (“MPG”), and the University Medical Center Göttingen (“UMG”), made a decision. Established to guide the BVXV-MPG-UMG NanoAb collaboration, the committee decided to focus the nanosized antibody (“NanoAb”) development on other therapeutic indications in addition to […]

Genprex Inc. (NASDAQ: GNPX) CMO Video Discusses Advances in Company’s Fight Against Tumors

Clinical-stage gene therapy developer Genprex (NASDAQ: GNPX) is expanding the breadth of its drug candidate potential with positive results from a preclinical study that examines the anti-tumor immune response of a gene believed to play a key role in suppressing certain tumors. Genprex’s lead drug candidate, REQORSA immunogene therapy, uses Genprex’s proprietary, non-viral ONCOPREX Nanoparticle […]

Freight Technologies Inc. (NASDAQ: FRGT) Shares anticipated 0-200% Revenue Growth for 2023; Reports Highest Monthly Increase in New Clients during month of March

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company on a mission to revolutionize cross-border shipping by offering carriers increased growth opportunities and shippers with flexibility, visibility, and simplicity, is working hard to have its best year yet. The company’s management recently updated its 2023 revenue guidance of $25-30 million, representing up to nearly 20% growth […]

Electronic Servitor Publication Network Inc. (XESP) Uses Smart Technology to Drive Unprecedented Growth for B2B Companies  

B2B businesses have seen an increased demand for digital assistance, especially for customer-driven marketing and associated communications. Electronic Servitor Publication Network (OTCQB: XESP), a digital engagement and activation company, offers a managed service that provides digital engagement and activation solutions for companies seeking to enhance their growth. The company is changing the landscape of digital […]

D-Wave Quantum Inc. (NYSE: QBTS) and Interpublic Group (NYSE: IPG) Announce Partnership to Use Quantum Computing Applications for Innovation in Marketing Investments and Strategies

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services focused on delivering customer value via practical quantum computing solutions, recently announced a partnership with one of the world’s leading global advertising and marketing services companies, Interpublic Group (NYSE: IPG). Through the partnership, D-Wave and IPG will work together on quantum computing […]

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) May Announcements Show Resolve to Continue Supporting R&D ‘Lifeblood’

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, held its 2023 Annual Meeting on the 9th of May, with shareholders voting on several agenda items, including the election of directors, appointment of auditors, approval of the stock option pricing, approval of the amendment to the maxim number of shares issuable pursuant to […]

Genprex Inc. (NASDAQ: GNPX) Announces Positive Data From Phase 1 Clinical Trial Evaluating REQORSA(R) Immunogene Therapy for Late-Stage Non-Small Cell Lung Cancer

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, recently announced that positive data from the Phase 1 portion of its Acclaim-1 clinical trial evaluating REQORSA(R) Immunogene Therapy in combination with Tagrisso(R) in late-stage non-small cell lung cancer (“NSCLC”) have been published in an abstract […]

 

From Our Blog

TechForce Robotics (NGTF) Expands Automation and AI Strategy to Capture High-Growth Service Markets

January 15, 2026

Nightfood Holdings Inc. (OTCQB: NGTF) d.b.a. TechForce Robotics, is slowly transitioning into a strategic investor and operator in sectors driven by innovation. With solid footprints in food services, hospitality, and real estate sectors, the company is incorporating artificial intelligence and robotic automation into its growth plan, underscoring a deeper focus on leading markets experiencing rapid […]

Rotate your device 90° to view site.